2. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder

Completed · Phase 3 · Has a placebo group

Conditions studied: Hypoactive Sexual Desire Disorder

In brief

A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial with an optional Open-label Extension to evaluate the efficacy of bremelanotide (BMT), administered subcutaneously (SC) on an as needed basis for the treatment of HSDD (with or without decreased arousal) in premenopausal females.

Key facts

Study ID

NCT02338960

Run by

Palatin Technologies, Inc

People needed

714

Starts

2015-01-01

Expected to finish

2017-06-29

Last updated by the study team

2021-01-28

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Palatin Clinical Site 218 — Phoenix, Arizona, United States
• Palatin Clinical Site 254 — Tucson, Arizona, United States
• Palatin Clinical Site 207 — Hot Springs, Arkansas, United States
• Palatin Clinical Site 258 — Beverly Hills, California, United States
• Palatin Clinical Site 256 — Garden Grove, California, United States
• Palatin Clinical Site 291 — Los Angeles, California, United States
• Palatin Clinical Site 270 — Oakland, California, United States
• Palatin Clinical Site 210 — San Diego, California, United States
• Palatin Clinical Site 251 — San Diego, California, United States
• Palatin Clinical Site 272 — Sherman Oaks, California, United States
• Palatin Clinical Site 253 — Tarzana, California, United States
• Palatin Clinical Site 212 — Denver, Colorado, United States
• Palatin Clinical Site 219 — Denver, Colorado, United States
• Palatin Clinical Site 243 — Lakewood, Colorado, United States
• Palatin Clinical Site 211 — New London, Connecticut, United States
• Palatin Clinical Site 229 — Waterbury, Connecticut, United States
• Palatin Clinical Site 202 — Washington D.C., District of Columbia, United States
• Palatin Clinical Site 204 — Aventura, Florida, United States
• Palatin Clinical Site 273 — Coral Gables, Florida, United States
• Palatin Clinical Site 203 — Fort Myers, Florida, United States
• Palatin Clinical Site 255 — Gainesville, Florida, United States
• Palatin Clinical Site 266 — Gainesville, Florida, United States
• Palatin Clinical Site 224 — Jupiter, Florida, United States
• Palatin Clinical Site 250 — Orlando, Florida, United States
• Palatin Clinical Site 242 — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.